Key Takeaways A Japanese health ministry panel backed full approval of Stemirac, a bone marrow cell therapy, on 15 October 2026. Reported data compared 73 treated patients with 66 untreated patients, and 40 treated patients improved in motor function. Treated patients received more rehabilitation, so it’s hard to isolate the
Key Takeaways Doctors can deliver stem cells for spinal cord injury through several routes, each with different reach and risk. Intravenous delivery is the least invasive route, but few cells actually reach the injury site. Intrathecal delivery is the most studied route in human trials, and a recent review links
Key Takeaways Stem cell therapy after spinal cord injury is studied for both traumatic and chronic cases, with different goals at each stage. A 2024 study found durable motor and sensory improvements in some patients five years after neural stem cell transplantation. A 2026 trial reported no serious safety concerns
